Literature DB >> 30768394

A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual.

Sally J Rogers1, Annette Estes2, Catherine Lord3, Jeff Munson2, Marie Rocha4, Jamie Winter3, Jessica Greenson2, Costanza Colombi5, Geraldine Dawson6, Laurie A Vismara4, Catherine A Sugar7, Gerhard Hellemann7, Fiona Whelan7, Meagan Talbott4.   

Abstract

OBJECTIVE: This single-blind, randomized, multisite, intent-to-treat study was designed to replicate and extend Dawson et al.'s (Pediatrics. 2010;125: e17-e23) randomized controlled trial testing the effects of the Early Start Denver Model (ESDM), an intensive play- and routines-based intervention delivered in natural settings.
METHOD: A randomized controlled trial was conducted at 3 universities. One hundred eighteen children 14 to 24 months old with autism spectrum disorder were enrolled and randomly assigned to ESDM or community interventions for 27 months. Eighty-one children completed the full treatment course and all assessments; data from all 118 children were used in analyses. Children assigned to the ESDM intervention received 3 months of weekly parent coaching followed by 24 months of 15 hour per week (on average) 1:1 treatment weekly on average in homes or daycare settings from supervised therapy assistants while parents received coaching 4 hours monthly from a certified ESDM therapist.
RESULTS: For the primary analyses, there were time-by-group and time-by-group-by-site interactions for language outcome. In the significant 3-way interaction involving site, 2 sites showed a significant ESDM advantage and the third site showed no significant group differences. In the planned 2-way analysis that pooled data across all 3 sites, there was a significant advantage found for the ESDM group. For the secondary analyses, there were no significant differences between the ESDM and community groups involving developmental quotient, autism severity, or adaptive behavior. The treatment effect of group on language outcomes was not moderated by baseline developmental quotient, autism severity, or language.
CONCLUSION: Results of the primary analysis provide a partial replication of Dawson et al.'s 2010 language findings. CLINICAL TRIAL REGISTRATION INFORMATION: Intensive Intervention for Toddlers with Autism; https://clinicaltrials.gov/; NCT00698997.
Copyright © 2019 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early Start Denver Model (ESDM); autism spectrum disorder; developmental quotient (DQ); early intervention; toddlers

Mesh:

Year:  2019        PMID: 30768394     DOI: 10.1016/j.jaac.2019.01.004

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  32 in total

1.  Quantifying Caregiver Change Across Early Autism Interventions Using the Measure of NDBI Strategy Implementation: Caregiver Change (MONSI-CC).

Authors:  Bethany A Vibert; Sarah Dufek; Claire B Klein; Yeo Bi Choi; Jamie Winter; Catherine Lord; So Hyun Kim
Journal:  J Autism Dev Disord       Date:  2020-04

2.  Integrating the Early Start Denver Model into Israeli community autism spectrum disorder preschools: Effectiveness and treatment response predictors.

Authors:  Yana Sinai-Gavrilov; Tali Gev; Irit Mor-Snir; Giacomo Vivanti; Ofer Golan
Journal:  Autism       Date:  2020-07-14

3.  Intervention Effects on Language in Children With Autism: A Project AIM Meta-Analysis.

Authors:  Micheal Sandbank; Kristen Bottema-Beutel; Shannon Crowley; Margaret Cassidy; Jacob I Feldman; Marcos Canihuante; Tiffany Woynaroski
Journal:  J Speech Lang Hear Res       Date:  2020-05-08       Impact factor: 2.297

4.  Policy and Practice Barriers to Early Identification of Autism Spectrum Disorder in the California Early Intervention System.

Authors:  Marian E Williams; Eliza K Harley; Irina Quebles; Marie Kanne Poulsen
Journal:  J Autism Dev Disord       Date:  2021-01-01

5.  Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis.

Authors:  Mark Rodgers; David Marshall; Mark Simmonds; Ann Le Couteur; Mousumi Biswas; Kath Wright; Dheeraj Rai; Stephen Palmer; Lesley Stewart; Robert Hodgson
Journal:  Health Technol Assess       Date:  2020-07       Impact factor: 4.014

6.  A Six-Minute Measure of Vocalizations in Toddlers with Autism Spectrum Disorder.

Authors:  Elena J Tenenbaum; Kimberly L H Carpenter; Maura Sabatos-DeVito; Jordan Hashemi; Saritha Vermeer; Guillermo Sapiro; Geraldine Dawson
Journal:  Autism Res       Date:  2020-03-25       Impact factor: 5.216

7.  The Early Start Denver Model Intervention and Mu Rhythm Attenuation in Autism Spectrum Disorders.

Authors:  Benjamin Aaronson; Annette Estes; Sally J Rogers; Geraldine Dawson; Raphael Bernier
Journal:  J Autism Dev Disord       Date:  2021-07-26

8.  Intensive behavioural interventions based on applied behaviour analysis for young children with autism: An international collaborative individual participant data meta-analysis.

Authors:  Mark Rodgers; Mark Simmonds; David Marshall; Robert Hodgson; Lesley A Stewart; Dheeraj Rai; Kath Wright; Esther Ben-Itzchak; Svein Eikeseth; Sigmund Eldevik; Hanna Kovshoff; Iliana Magiati; Lisa A Osborne; Phil Reed; Giacomo Vivanti; Ditza Zachor; Ann Le Couteur
Journal:  Autism       Date:  2021-01-22

9.  Mindfulness-Based Stress Reduction for Parents Implementing Early Intervention for Autism: An RCT.

Authors:  Amy S Weitlauf; Neill Broderick; J Alacia Stainbrook; Julie Lounds Taylor; Catherine G Herrington; Amy G Nicholson; Madeline Santulli; Elisabeth M Dykens; A Pablo Juárez; Zachary E Warren
Journal:  Pediatrics       Date:  2020-04       Impact factor: 7.124

Review 10.  Autism spectrum disorder.

Authors:  Catherine Lord; Traolach S Brugha; Tony Charman; James Cusack; Guillaume Dumas; Thomas Frazier; Emily J H Jones; Rebecca M Jones; Andrew Pickles; Matthew W State; Julie Lounds Taylor; Jeremy Veenstra-VanderWeele
Journal:  Nat Rev Dis Primers       Date:  2020-01-16       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.